Intravitreal Injection of Ozurdex(®) Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up

AIM: To evaluate the efficacy of intravitreal dexamethasone injections in diabetic macular edema (DME). METHODS: A 700 μg slow-release intravitreal dexamethasone implant (Ozurdex®) was placed in the vitreal cavity of 17 patients (19 eyes) affected with persistent DME. Best corrected visual acuity (B...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacella, Fernanda, Ferraresi, Adriana Francesca, Turchetti, Paolo, Lenzi, Tommaso, Giustolisi, Rosalia, Bottone, Andrea, Fameli, Valeria, Romano, Maria Rosaria, Pacella, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852759/
https://www.ncbi.nlm.nih.gov/pubmed/27147895
http://dx.doi.org/10.4137/OED.S38028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852759/
https://www.ncbi.nlm.nih.gov/pubmed/27147895
http://dx.doi.org/10.4137/OED.S38028

Ejemplares similares